311.43
Bio Rad Laboratories Inc stock is traded at $311.43, with a volume of 252.59K.
It is down -2.54% in the last 24 hours and up +1.94% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$319.55
Open:
$317.04
24h Volume:
252.59K
Relative Volume:
1.00
Market Cap:
$6.85B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.40
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-7.35%
1M Performance:
+1.94%
6M Performance:
+31.77%
1Y Performance:
-15.47%
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BIO
Bio Rad Laboratories Inc
|
311.43 | 8.62B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Using R and stats models for Bio Rad Laboratories Inc. forecastingWeekly Investment Recap & Step-by-Step Swing Trade Plans - newser.com
Is Bio Rad Laboratories Inc. forming a bottoming baseJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherJuly 2025 Snapshot & Target Return Focused Picks - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 daysJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com
Assetmark Inc. Buys 12,023 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
HbA1c Testing Market Research Report 2025-2033, Profiles of - GlobeNewswire
HbA1c Testing Market Research Report 2025-2033, Profiles of Key PlayersDanaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics - Yahoo Finance
How Bio Rad Laboratories Inc. (BUW) stock stacks up against competitorsPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Will Bio Rad Laboratories Inc. Class B stock deliver stable dividends2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyTake Profit & Weekly High Return Forecasts - newser.com
Is Bio Rad Laboratories Inc. meeting your algorithmic filter criteria2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
Understanding Bio Rad Laboratories Inc.’s price movementQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stock2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. stock poised for growthPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO? - Yahoo Finance
Bio Rad Laboratories Inc. stock trend forecast2025 Year in Review & Smart Allocation Stock Reports - newser.com
Assessing Bio-Rad Laboratories’s Valuation After Posting a Sharp Quarterly Net Loss Despite Stable Sales - Sahm
Is Bio-Rad (BIO) Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships? - simplywall.st
How Bio Rad Laboratories Inc. (BUW) stock reacts to weak economyPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
How to build a dashboard for Bio Rad Laboratories Inc. stockDay Trade & Weekly Top Stock Performers List - newser.com
Will Bio Rad Laboratories Inc. stock recover after recent dropPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Will Bio Rad Laboratories Inc. Class stock sustain bullish trend into 2025Gap Up & Entry Point Strategy Guides - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. Class stockMarket Volume Summary & AI Driven Stock Movement Reports - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock beat Nasdaq index returns2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
GAM Holding AG Acquires New Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
What technical charts say about Bio Rad Laboratories Inc. stockEarnings Overview Report & Safe Entry Point Identification - newser.com
Wall Street Zen Upgrades Bio-Rad Laboratories (NYSE:BIO) to Buy - MarketBeat
Is Bio Rad Laboratories Inc. stock a bargain at current levelsJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
Will Bio Rad Laboratories Inc. Class stock outperform value peersWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
How Bio Rad Laboratories Inc. Class B stock responds to bond marketPortfolio Return Summary & Weekly High Return Stock Opportunities - newser.com
Will Bio Rad Laboratories Inc. outperform the marketQuarterly Investment Review & Weekly High Potential Alerts - newser.com
Bio-Rad Laboratories, Inc. $BIO Stock Holdings Increased by State of New Jersey Common Pension Fund D - MarketBeat
Can Bio Rad Laboratories Inc. stock sustain revenue growth2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
What recovery options are there for Bio Rad Laboratories Inc.July 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Given New $375.00 Price Target at Citigroup - MarketBeat
Weiss Ratings Upgrades Bio-Rad Laboratories (NYSE:BIO) to Hold (C-) - MarketBeat
Wells Fargo & Company Raises Bio-Rad Laboratories (NYSE:BIO) Price Target to $340.00 - MarketBeat
Future Scope of Laboratory Reagent Market Set to Witness - openPR.com
Bio-Rad sales up 0.5% to USD 653M in Q3 2025 - Medical Buyer
How to manage a losing position in Bio Rad Laboratories Inc.Market Weekly Review & Safe Entry Momentum Tips - newser.com
Why global investors buy Bio Rad Laboratories Inc. (BUWA) stock2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):